This compound is a pharmaceutical intermediate specifically designed for peptide synthesis. It features a complex structure with multiple amide and ether linkages, protected by tert-butyl and fluorenylmethoxycarbonyl (Fmoc) groups, and is characterized by high molecular weight and lipophilicity.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 1662688-20-1
FMOC-L-LYS[C20-OTBU-GLU(OTBU)-AEEA-AEEA]-OH
Research compound for peptide synthesis
(25S,43S)-43-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-25-(tert-butoxycarbonyl)-2,2-dimethyl-4,23,28,37-tetraoxo-3,32,35-trioxa-24,29,38-triazatetratetracontan-44-oic acid
Research compound for peptide synthesis
Fmoc-L-Lys[C20-OtBu-L-Glu(OtBu)-AA-AA]-OH
Pharmaceutical intermediate for peptide synthesis
Fmoc-Lys[|A-Glu(OtBu)-C18-OtBu)]-OH
solid phase peptide synthesis reagent
(2S)-2-{[(tert-butoxy)carbonyl]amino}-5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid
peptide synthesis intermediate
Boc-His(Trt)-Aib-OH
peptide synthesis intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]butanoic acid
peptide synthesis intermediate
Fmoc-AEEA-AEEA
peptide synthesis intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetyl]amino]hexanoic acid
COTQASXXEXJBOM-PJYGOTMFSA-N
CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C